Plasma HDL in patients with CKD show a selective reduction of LpA-I–A-II particles [16], likely explained by an accelerated catabolism of these particles when LCAT activity is reduced, as observed in genetic LCAT deficiency [23]. This evidence concerns the gene LCAT and chronic kidney disease.